摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione | 252268-48-7

中文名称
——
中文别名
——
英文名称
(S)-2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione
英文别名
5-Hydroxymethyl-2-methyl-5,8-dihydro-[1,2,4]triazolo[1,2-A]pyridazine-1,3-dione;(5S)-5-(hydroxymethyl)-2-methyl-5,8-dihydro-[1,2,4]triazolo[1,2-a]pyridazine-1,3-dione
(S)-2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione化学式
CAS
252268-48-7
化学式
C8H11N3O3
mdl
——
分子量
197.194
InChiKey
YXLVIORYJGPOCZ-LURJTMIESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.9
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    64.1
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Chemoenzymatic Synthesis of Enantiopure 1-Azafagomine
    摘要:
    A new chemoenzymatic synthesis of both enantiomeric forms of the glycosidase inhibitor 1-azafagomine (1) is reported. The synthesis starts from the achiral starting materials pentadienol and methylurazol with the key steps being a hetero-Diels-Alder reaction followed by a lipase R/Novozym 435-catalyzed enantioselective esterification of the Diels-Alder adduct.
    DOI:
    10.1021/jo9907989
  • 作为产物:
    描述:
    (S)-2-acetoxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione 在 sodium carbonate 作用下, 以 甲醇 为溶剂, 反应 4.0h, 以76%的产率得到(S)-2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione
    参考文献:
    名称:
    Chemoenzymatic Synthesis of Enantiopure 1-Azafagomine
    摘要:
    A new chemoenzymatic synthesis of both enantiomeric forms of the glycosidase inhibitor 1-azafagomine (1) is reported. The synthesis starts from the achiral starting materials pentadienol and methylurazol with the key steps being a hetero-Diels-Alder reaction followed by a lipase R/Novozym 435-catalyzed enantioselective esterification of the Diels-Alder adduct.
    DOI:
    10.1021/jo9907989
点击查看最新优质反应信息

文献信息

  • Synthesis of 1-azagalactofagomine, a potent galactosidase inhibitor
    作者:Henrik Helligsø Jensen、Mikael Bols
    DOI:10.1039/b007973l
    日期:——
    1-Azagalactofagomine [(+)-(3R,4S,5R)-4,5-Dihydroxy-3-(hydroxymethyl)hexahydropyridazine, 2] was synthesised from achiral starting materials in a chemoenzymic synthesis. The racemic Diels–Alder adduct (2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione, 5) from addition of pentadienol to 4-methyl-1,2,4-triazoline-3,5-dione was resolved using lipase R-catalysed acetylation. The acetate [(S)-2-acetoxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione, 6] was saponified and treated with MCPBA to give a majority of the syn epoxide [(2R,3S,4R)-3,4-epoxy-2-hydroxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]nonane-7,9-dione, 7]. This isomer was subjected to epoxide opening with HI followed by a Woodward reaction-like displacement of the iodide with water and peracetylation to give an all-syn triacetate [(2R,3S,4R)-3,4-diacetoxy-2-acetoxymethyl-1,6,8-triazabicyclo[4.3.0]nonane-7,9-dione, 11]. Finally deacetylation and hydrazinolysis gave 2. The pKa of 2 was determined to be 5.7. 1-Azagalactofagomine was found to be a potent competitive galactosidase inhibitor. The inhibition constants, Ki, were 40, 300 and 7800 nM versus β-galactosidase from Aspergillusoryzae, Eschinchia coli and Saccharomyces fragilis, respectively, and 280 nM vs. α-galactosidase from green coffee beans.
    1-氮杂半乳糖胺[(+)-(3R,4S,5R)-4,5-二羟基-3-(羟甲基)六氢哒嗪,2]是通过化学酶合成由非手性起始原料合成的。戊二烯醇加成至 4-甲基- 外消旋狄尔斯-阿尔德加合物 (2-羟甲基-8-甲基-1,6,8-三氮杂双环[4.3.0]non-3-烯-7,9-二酮, 5)使用脂肪酶 R 催化的乙酰化拆分 1,2,4-三唑啉-3,5-二酮。将乙酸酯[(S)-2-乙酰氧基甲基-8-甲基-1,6,8-三氮杂双环[4.3.0]壬-3-烯-7,9-二酮, 6]皂化并用MCPBA处理,得到大部分顺式环氧化物 [(2R,3S,4R)-3,4-环氧-2-羟甲基-8-甲基-1,6,8-三氮杂双环[4.3.0]壬烷-7,9-二酮, 7] 。该异构体用 HI 进行环氧化物开环,然后用水进行类似伍德沃德反应的碘化物置换,并进行全乙酰化,得到全顺式三乙酸酯 [(2R,3S,4R)-3,4-二乙酰氧基-2-乙酰氧基甲基- 1,6,8-三氮杂双环[4.3.0]壬烷-7,9-二酮,11]。最后脱乙酰基和肼解得到2。2的pKa测定为5.7。 1-Azagalactofagomine 被发现是一种有效的竞争性半乳糖苷酶抑制剂。抑制常数 Ki 分别为 40、300 和 7800 nM 分别来自米曲霉、大肠杆菌和脆弱酵母的 β-半乳糖苷酶,以及 280 nM 与来自绿咖啡豆的 α-半乳糖苷酶。
  • Chemoenzymatic Synthesis of Enantiopure 1-Azafagomine
    作者:Xifu Liang、Mikael Bols
    DOI:10.1021/jo9907989
    日期:1999.11.1
    A new chemoenzymatic synthesis of both enantiomeric forms of the glycosidase inhibitor 1-azafagomine (1) is reported. The synthesis starts from the achiral starting materials pentadienol and methylurazol with the key steps being a hetero-Diels-Alder reaction followed by a lipase R/Novozym 435-catalyzed enantioselective esterification of the Diels-Alder adduct.
查看更多

同类化合物

苯乙酰胺,4-[1-乙基-1-[4-(3-羟基-3,4,4-三甲代戊基)-3-甲基苯基]丙基]-a-羟基-2-甲基- 嗪多群 伯瑞替尼 [1-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基甲基]环己基]甲烷磺酰胺 [1,2,4]噻唑并[4,3-b]吡嗪-6-羧酸 [1,2,4]三唑并[4,3-b]哒嗪-8-甲酰胺 [1,2,4]三唑并[4,3-b]哒嗪-6-胺 [1,2,4]三唑并[4,3-b]哒嗪-3-羧酸 [1,2,4]三唑并[4,3-b]哒嗪-3-甲醛 [1,2,4]三唑并[4,3-b]哒嗪-3-甲酰胺 [1,2,4]三唑并[4,3-b]哒嗪-3,6-二胺 N,N-二甲基-3-([1,2,4]三唑并[1,5-b]哒嗪-6-氧基)丙烷-1-磺酰胺 7-氨基-6-甲基-[1,2,4]噻唑并-[4,3-b]吡嗪-8-醇 6H-嘌呤-6-硫酮,3-乙基-3,9-二氢- 6-肼基[1,2,4]噻唑并[4,3-b]吡嗪 6-肼基-3-甲基[1,2,4]三唑并[4,3-b]哒嗪 6-甲氧基-[1,2,4]三唑并[4,3-B]哒嗪 6-甲基-[1,2,4]噻唑并[4,3-b]吡嗪 6-甲基-[1,2,4]噻唑并[1,5-b]吡嗪 6-甲基-[1,2,4]三唑并[4,3-B]哒嗪-8-胺 6-氯[1,2,4]噻唑并[4,3-b]吡嗪-3-胺 6-氯[1,2,4]噻唑并[4,3-b]吡嗪-3-硫醇 6-氯[1,2,4]噻唑并[1,5-b]吡嗪 6-氯-[1,2,4]噻唑并[1,5-b]吡嗪-2-羧酸甲酯 6-氯-[1,2,4]三唑并[4,3-b]哒嗪-3-羧酸甲酯 6-氯-[1,2,4]三唑并[4,3-B]哒嗪-3-羧酸乙酯 6-氯-[1,2,4]三唑并[1,5-b]哒嗪-2-羧酸 6-氯-3-甲基[1,2,4]三唑并[4,3-B]哒嗪 6-氯-3-甲基-[1,2,4]三唑并[4,3-B]哒嗪-8-胺 6-氯-3-(三氟甲基)[1,2,4]噻唑并[4,3-b]吡嗪 6-氯-2-甲基-s-噻唑并[1,5-b]吡嗪 6-氯-2-(三氟甲基)-[1,2,4]噻唑并[1,5-b]吡嗪 6-氯-2-(1,1-二甲基乙基)-[1,2,4]三唑并[1,5-b]哒嗪 6-氯-1,2,4-三唑并[4,3-b]哒嗪 6-乙氧基-5H-[1,2,4]三唑并[4,3-b]哒嗪-8-酮 6-(三氟甲基)-[1,2,4]三唑并[4,3-B]哒嗪 6,8-二甲基-1,2,4-三唑并[4,3-B]哒嗪 5-乙基-5-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基甲基]庚烷-1-磺酰胺 5,5-二甲基-6-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基]己烷-1-磺酰胺 4,4-二甲基-5-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基]戊烷-1-磺酰胺 3-甲基-7-(2-苯基乙基)[1,2,4]三唑并[4,3-b]哒嗪 3-甲基-2-{[(7-甲基[1,2,4]三唑并[1,5-b]哒嗪-6-基)氧代]甲基}丁烷-1-磺酰胺 3-溴-[1,2,4]三唑并[4,3-B]哒嗪 3-氯-[1,2,4]三唑并[4,3-b]哒嗪 3-氯-6-甲基[1,2,4]三唑并[4,3-B]哒嗪 3-[(7,8-二甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基]-2,2-二甲基丙烷-1-磺酰胺 3,6-二氯并[1,2,4]噻唑并[4,3-b]哒嗪 2-甲基-2-丙基6-氯[1,2,4]三唑并[1,5-b]哒嗪-2-羧酸酯 2-甲基-2-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基甲基]丁烷-1-磺酰胺 2-[1-[(7-甲基-[1,2,4]三唑并[5,1-f]哒嗪-6-基)氧基甲基]环己基]乙烷磺酰胺